Mild HBO
Mild hyperbaric oxygen is not hyperbaric oxygen therapy. The following was obtained from the SAUHMA website.
SAUHMA Position Statement: Low-Pressure Fabric Hyperbaric Chambers
Overview:
The low-pressure, fabric hyperbaric chambers (operating at less than 1.4 ATA) marketed for sports and alternative medicine, have a U.S. Food & Drug Administration (FDA) 510(k) clearance for Acute Mountain Sickness only and are designed to be compressed only with air. The FDA prohibits the use of these devices with supplemental oxygen.
In South Africa, there is no Medicines Control Council review or cautionary statements, nor concerns raised by the Department of Labour at this stage.
The internationally recognized NFPA 101 Life Safety Code and NFPA 99 Health Care Facilities Code describe the requirements for the construction, operation, and maintenance of hyperbaric facilities.
The Pressure Equipment Regulations (through SANS 347) classifies a typical Gamow bag (based on volume and maximum operating pressure at less than 1.5 ATA) as Category “Not regulated”. The low-pressure fabric hyperbaric chamber thus falls outside of any regulated requirements.
The Diving Regulations specify that all persons exposed to pressures in excess of 100 millibar above ambient pressure (1.1 ATA) are required to conform to the requirements of these regulations, unless the treatment concerns medical conditions (non-diving) and in this case, the facility providing such treatments is required to be accredited by SAUHMA.
SANS 347 Annex A provides a schedule of health and safety standards approved by the Department of Labour. ASME PVHO-1 is listed as an approved safety standard.
The ASME-PVHO-1 standard applies to any pressure vessel that encloses a human within the pressure boundary, with an external or internal pressure exceeding 2 psig above ambient pressure (1.14 atmospheres absolute).
SAUHMA’s approved indications require that treatment pressures given be at a minimum of 2 ATA. At this pressure, the pressure vessel is categorized as a Category III vessel, subject to all the design, construction, testing and certification requirements listed in SANS 347.
Accordingly, SAUHMA requires that all hyperbaric chamber construction is required to satisfy Category III requirements, as a minimum, and shall meet the relevant ASME-PVHO-1 requirements.
The SANS 347 vessel conformity categorization as Not Regulated is not appropriate where human occupancy adds a considerable safety responsibility to any pressure vessel product.
As considered by the UHMS, SAUHMA does not endorse the concept of “In Home” therapy at any time.
Conclusions and Recommendations:
Hyperbaric oxygen therapy is defined as an intervention in which an individual breathes near 100% oxygen while [wholly enclosed] inside a hyperbaric chamber at a pressure equal to or greater than 1.4 ATA. SAUHMA approved indications commence at pressures greater or equal to 2 ATA. Low-pressure hyperbaric chambers, at pressures equal to or less than 1.4 ATA approved for acute mountain sickness only. Mild hyperbaric exposures with air, deliver no more oxygen to the body than breathing oxygen by mask at sea level pressure. Exposure to treatment pressures less than 2.0 ATA while breathing air does not meet the SAUHMA definition of therapeutic hyperbaric oxygen therapy and does not achieve the minimum pressure and oxygen levels required for any SAUHMA approved indication. All SAUHMA approved indications require that the patient breathe near 100% oxygen while enclosed in a chamber pressurized to a minimum of 2 ATA. SAUHMA does not recommend the use of mild hyperbaric therapy for any medical purpose other than acute mountain sickness.
[1] Food and Drug Administration, CFR _Code of Federal Regulations Title 21
[2] National Fire Protection Association, 101 Life Safety Code 2015 edition
[3] National Fire Protection Association, 99 Health Care Facilities Code, 2015 edition
[4] SANS 347: Categorization and conformity assessment criteria for all pressure equipment, 2nd Ed, 2012
[5] ASME PVHO-1, Safety standard for pressure vessels for human occupancy, 2015.
[6] Undersea and Hyperbaric Medical Society Position Statement on the Conduct of Hyperbaric Oxygen Therapy
What we found when we read the “mild” literature in full
Added 4 November 2026. The position statement above is SAUHMA’s, quoted unchanged. What follows is our own, from reading the primary papers rather than summaries of them — and it supports the statement for a reason worth setting out, because it is a reason a patient can check.
The arithmetic first. A typical “mild” session is 1.3 atmospheres breathing about 24% oxygen. That works out to an inspired oxygen pressure of roughly 0.31 atmospheres, against 0.21 breathing ordinary air at sea level — an alveolar oxygen tension of about 175 mmHg, which is roughly what a 28 to 30% Venturi mask delivers in a hospital ward at normal pressure, with no chamber at all. True hyperbaric oxygen therapy at 2.4 atmospheres on 100% oxygen reaches around ten times that. The two are not the same treatment at a different dose; they are different treatments.
Then the evidence that is usually cited for it. We read in full a 2003 congress paper reporting eleven patients given ten sessions at 1.3 atmospheres on 24% oxygen for attention problems attributed to chemical exposure. Three things about it are worth knowing. Its central claim, that “all patients showed improvement”, is contradicted by its own table: of 55 scores, 8 fell and 3 did not move, five of the eleven patients got worse on at least one scale, and one fell by 28 points. A quarter of the starting scores were at the very bottom of the test’s range, printed as “below 40”, where the only direction available is up and the size of any change cannot be measured. And the one proper controlled trial it cites as proof — a 2001 Lancet trial in children with cerebral palsy — used 1.3 atmospheres as its placebo. In that trial both groups improved about equally, and the authors attributed the improvement to taking part in a trial rather than to the chamber. A placebo arm is being quoted as evidence that the placebo works.
None of this means pressurised air is harmful, and none of it is a criticism of people who have felt better after using such a chamber — feeling better after attention, rest and a daily routine is real. It means that if someone offers you a 1.3-atmosphere chamber for a medical condition, the plain description of what you are buying is an hour of something close to a 30% oxygen mask, and that the published evidence offered in support does not hold up when the tables are checked. We are glad to discuss any specific claim you have been shown.
- Heuser G, Aguilera O, Heuser S, Reeves J, Rogowski C. Hyperbaric oxygen treatment in a portable chamber improves attention span and reaction time in patients with acquired ADD. In: Cramer FS, Sheffield PJ, eds. Proceedings of the Fourteenth International Congress on Hyperbaric Medicine. Flagstaff, AZ: Best Publishing Company, 2003:273-282. ISBN 1-930536-13-5. Not indexed on PubMed; no DOI.
- Collet JP, Vanasse M, Marois P, et al. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. Lancet. 2001;357(9256):582-6. PMID 11558483 · DOI 10.1016/S0140-6736(00)04054-X


Contact us
Tel: 012 335 8651 · Email: [email protected]
